Sundial vs. HEXO: Which Cannabis Stock is a Better Buy?

: SNDL | Sundial Growers Inc. News, Ratings, and Charts

SNDL – Sundial (SNDL) and HEXO (HEXO) have gained momentum in the last few trading sessions. However, only one of these rallies seems sustainable. While Sundial is looking to shift its business model, HEXO is aggressively expanding via acquisitions. Which cannabis stock should you buy today?.

Stocks in the cannabis industry continue to remain volatile but also allow investors to derive market-beating gains due to a rapidly expanding market driven by expectations of marijuana legalization in the U.S.

Most Canadian marijuana producers are grappling with mounting losses, and lower than expected demand. These factors have led pot stocks to trail the broader markets by a significant margin. Now, cannabis companies are focused on streamlining operations, reducing cash burn, and shifting their product mix which should lead to a recovery in share prices.

Keeping this in mind, today we compare Sundial Growers (SNDL) with HEXO Inc (HEXO) to see which pot stock should be on your shopping list right now.

SNDL stock has skyrocketed in the past month

Shares of Sundial have gained momentum this week and are up 68% in the past month. This is likely because of a Redditt-fueled rally driven by retail traders on the social platform. Other meme stocks such as BlackBerry, GameStop, and AMC Entertainment have also exploded in the last few trading sessions. Despite the recent uptick, SNDL stock is down 70% from all-time highs, and for good reason.

In the first quarter of 2021, Sundial Growers saw its sales decline by 32% year over year to $9.9 million. Sundial said it will drastically reduce its product portfolio and focus on selling high-margin items which will improve its bottom-line.

It has also invested close to $100 million in other cannabis producers and derived $15.7 million via non-cannabis sales. This allowed the company to post a positive adjusted EBITDA in Q1 despite a negative gross margin. In case Sundial continues to focus on non-cannabis sales, it might become a marijuana financier rather than a licensed producer.

One of the things working for Sundial is its high cash balance of $746 million and debt-free balance sheet. It can use available liquidity to purchase companies that will be accretive to its revenue and profit margins. Sundial recently announced it’s looking to acquire Inner Spirit that has 19 stores and 67 franchise locations. In Q4 of 2020, Inner Spirit grew sales by 13.6% to $9.2 million and improved EBITDA margin by three percentage points to 19%.

However, Sundial is valued at a market cap of $2.4 billion indicating a forward price to sales multiple of an astonishing 54.6x. Comparatively, its revenue in 2021 is forecast to decline by 3.4% to $48.9 million.

HEXO stock is up 82% in 2021

Shares of HEXO have gained 82% year to date but are still trading 80% below its record high. HEXO stock gained momentum last week after it announced its intention to acquire Redecan for $925 million. HEXO will pay $400 million in cash and $525 million in stock to acquire Redecan which is the largest privately-owned licensed producer in Canada.

The Canadian pot giant has been on an acquisition spree this year. In February, HEXO announced it will acquire Zenabis Global in an all-stock deal valued at $235 million. Last month, HEXO disclosed it will acquire 48North Cannabis in an all-stock deal valued at $50 million.

HEXO explains Redecan will help it gain traction in the Canadian recreational pot market. Likewise, the Zenabis buyout will help it gain a foothold in Europe while massively increasing its production capacity. HEXO has forecast it might generate over $30 million in cost synergies via the acquisitions of Zenabis and 48North Cannabis.

Zenabis reported sales of $59 million in the last year and this figure for 48North Cannabis stands at $17 million. It suggests HEXO should easily generate over $300 million in annual sales once the above three acquisitions are closed, making it one of the largest cannabis companies in Canada. In fiscal 2020, HEXO reported sales of $81 million.

HEXO stock is valued at a market cap of $845 million which means its trading at a reasonable valuation. The company also reported positive adjusted EBITDA and 94% increase in net revenue from prior year in its latest earnings report. While the acquisitions will lead to increased costs in the near term, HEXO should benefit from synergies post-integrations.

The verdict

HEXO and Sundial have consistently reported huge losses in the last few quarters and burnt massive amounts of cash. However, HEXO’s significantly lower valuation and latest acquisitions make it a better stock to bet on right now. I believe this is especially true if you account for Sundial’s Redditt-fueled rally which will likely come to an abrupt end soon.


SNDL shares were trading at $1.19 per share on Friday morning, down $0.11 (-8.14%). Year-to-date, SNDL has gained 151.32%, versus a 13.23% rise in the benchmark S&P 500 index during the same period.


About the Author: Aditya Raghunath


Aditya Raghunath is a financial journalist who writes about business, public equities, and personal finance. His work has been published on several digital platforms in the U.S. and Canada, including The Motley Fool, Finscreener, and Market Realist. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
SNDLGet RatingGet RatingGet Rating
HEXOGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


How Low Could Stocks Go?

The S&P 500 (SPY) is starting to test key support levels for the first time since November 2023 given continuing signs that Fed rate cuts are getting pushed further and further into the future. This begs the question of “how low could stocks go?” 44 year investment veteran Steve Reitmeister does his level best to answer that question including a trading plan and top picks to stay one step ahead of the market. Read on below for the full story...

3 Biotech Stocks to Buy to Power Through April

The biotech sector is primed for growth, fueled by a surge in FDA approvals, anticipated M&A deals, and the integration of AI in drug discovery. So, fundamentally sound biotech stocks Theratechnologies (THTX), Harmony Biosciences (HRMY), and Shionogi & Co. (SGIOY) might be solid buys in this month. Keep reading...

Check out These 3 Internet Stocks for Potential Gains

Amplified internet usage, technological advancements, and a rising digital transformation worldwide have driven the internet industry rapidly. To that end, quality internet stocks Wix.com (WIX), Tripadvisor (TRIP), and Yelp (YELP) could be solid buys now. Read on…

Top 3 Financial Services Stocks With Unstoppable Momentum

The financial services sector is set for solid growth owing to global economic trends, technological advancements making digital services more accessible, and changing consumer preferences.Therefore, investors could consider buying fundamentally strong financial services stocks Broadridge Financial Solutions (BR), Banco Macro (BMA), and Yiren Digital (YRD) as they look well-positioned to continue their momentum. Read more...

Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

Read More Stories

More Sundial Growers Inc. (SNDL) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SNDL News